ResearcherKansai Medical UniversityActive in the last 2 years
Denys Tsybulskyi
Matched on OpenAlex author ID A5093471646. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression M… Co-author DOI 10.1002/jhbp.70054↗
- Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal… Co-author DOI 10.1245/s10434-024-16361-y↗
- Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib. Co-author DOI 10.1186/s40792-024-01975-x↗
- Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospectiv… Co-author DOI 10.21037/jgo-23-655↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- So Yamaki · 4 shared papers, 2023–2026 · strength 0.81
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x↗
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Sohei Satoi · 4 shared papers, 2023–2026 · strength 0.81
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x↗
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Daisuke Hashimoto · 4 shared papers, 2023–2026 · strength 0.81
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x↗
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Yuki Matsui · 3 shared papers, 2023–2025 · strength 0.61
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x↗
- Paper Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous me… DOI 10.21037/jgo-23-655↗
- Hidetaka Miyazaki · 2 shared papers, 2024–2025 · strength 0.43
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x↗
- Tsukasa Ikeura · 2 shared papers, 2023–2025 · strength 0.40
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous me… DOI 10.21037/jgo-23-655↗
- Mitsugu Sekimoto · 2 shared papers, 2023–2025 · strength 0.40
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y↗
- Paper Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous me… DOI 10.21037/jgo-23-655↗
- Masashi Kanai · 1 shared paper, 2025 · strength 0.22
- Takumi Funo · 1 shared paper, 2024 · strength 0.21
- Yosuke Inoue · 1 shared paper, 2026 · strength 0.20
- Teiichi Sugiura · 1 shared paper, 2026 · strength 0.20
- Kenjiro Okada · 1 shared paper, 2026 · strength 0.20
- Shoki Sato · 1 shared paper, 2026 · strength 0.20
- Ryuta Shintakuya · 1 shared paper, 2026 · strength 0.20
- Masamichi Mizuma · 1 shared paper, 2026 · strength 0.20
- Toshimichi Asano · 1 shared paper, 2026 · strength 0.20
- Atsushi Oba · 1 shared paper, 2026 · strength 0.20
- Kenichiro Uemura · 1 shared paper, 2026 · strength 0.20
- Daisuke Ban · 1 shared paper, 2026 · strength 0.20
- Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.20
- Nobuhiko Nakagawa · 1 shared paper, 2026 · strength 0.20
- Aistė Gulla · 1 shared paper, 2026 · strength 0.20
- Koetsu Inoue · 1 shared paper, 2026 · strength 0.20
- Michiaki Unno · 1 shared paper, 2026 · strength 0.20
- Satoshi Hirano · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.